Telemedicine consultations are being highly publicized for the management of dry eye disease amidst the coronavirus pandemic.
Telehealth Services Boost Uptake of Anti-inflammatory Products amidst COVID-19 Outbreak
Telemedicine consultations are being highly publicized for the management of dry eye disease amidst the coronavirus (COVID-19) pandemic. Clinicians are resorting to Zoom videoconference, since patients are creating a demand for remote healthcare services. Thus, telemedicine holds promising potentials in revenue generation activities for companies in the dry eye disease treatment market.
Read Report Overview - https://www.transparencymarketresearch.com/dry-eye-disease-treatment-market.html
More number of patients have been appreciative about telehealth services. This has helped to increase the uptake of anti-inflammatory and artificial tears products. However, clinicians are coming across compliance issues in patients such as erratic consumption of their omega-3 fatty acid supplements. Hence, doctors are holding positive hopes for the pandemic to subside soon so that they can provide written prescriptions and special instructions to patients for effective management of DED. This is likely to drive the dry eye disease treatment market.
Request Brochure of Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=77640
Intense Pulsed Light Technology Devices Help Reduce Inflammation in DED Patients
Although anti-inflammatory and artificial tears products hold a major share of the revenue in the dry eye disease treatment market, manufacturers are innovating in state-of-the-art devices to improve patient outcomes. For instance, Device Technologies AU-a medical devices supplier to Australia and New Zealand, is strengthening its distribution channels for medical equipment manufacturer Quantel Medical’s device LacryStim IPL that helps in treating DED. As such, device manufacturers in the dry eye disease treatment market are gaining proficiency in intense pulsed light technology, which is intended to treat dry eye diseases such as meibomian gland dysfunction. Thus, technological innovations contribute a modest share to the market, which is predicted to expand at a CAGR of ~4% during the forecast period.
Device manufacturers are aiming to acquire European regulatory clearance for the intense pulsed light technology that is instrumental in reducing inflammation in DED patients.
Request for Analysis of COVID-19 Impact on Dry Eye Disease Treatment Market- https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=77640
Novel Contact Lenses Emerge as Effective Solution for Dry Eye Disease
Innovative contact lens hold promising potentials for dry eye disease treatment. For instance, Swanson School of Engineering graduate student researcher Alexis Nolfi who is suffering from the disease from the past several years, has introduced CyteSolutions Lens that target inflammatory dry eye pathways. Researchers in the dry eye disease treatment market are collaborating with eye doctors to innovate in contact lenses that are capable of replacing artificial tears products. Such breakthrough innovations are bolstering the growth for the dry eye disease treatment market, which is estimated to cross the value of ~US$ 8.7 Bn by the end of 2030.
Inadequate relief from artificial tears products are posing as a challenge for companies in the market for dry eye disease treatment. Hence, companies in the market for dry eye disease should collaborate with researchers and innovators to design contact lenses that help in the management of inflammatory dry eye pathways.
Request for Custom Research - https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=77640
Multistage Management Algorithm Holds Potential to Prevent Progression of DED
The growing awareness about multistage management algorithm for dry eye disease is acquiring increased credibility, owing to its evidence-based and personalized approach. Healthcare companies in the dry eye disease treatment market are increasing their R&D muscle to develop products that restore the homeostasis of the ocular surface and tear film of the eyes. The Tear Film and Ocular Surface Society (TFOS) is working relentlessly to create awareness about multistage management algorithms for the management of dry eye disease.
Pre Book Dry Eye Disease Treatment Market Report - https://www.transparencymarketresearch.com/checkout.php?rep_id=77640<ype=S
Healthcare companies in the dry eye disease treatment market are increasing efforts to educate patients about the negative ramifications of dry eye disease, which is emerging as a key solution to prevent its progression. Manufacturers are increasing their production capabilities to develop fatty acid oral supplements that help to improve overall patient comfort.
About Us
Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.
Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through ad hoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.
TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.
Contact
Mr. Rohit Bhisey
Transparency Market Research
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: https://www.transparencymarketresearch.com/